尼康精机(上海)有限公司 | Chinese Mainland
- zh Change Region
- Global Site
2026年4月
Three-dimensional organ-on-chip (OoC) platforms provide physiologically relevant models for angiogenesis research, enabling clearer insights into vessel formation and drug responses. Yet their intricate microfluidic architecture requires specialized imaging for reliable, high-quality data. A dedicated, automated imaging workflow ensures consistent, high-resolution data that accelerate and strengthen your drug-development decisions.